Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 5:48 PM UTC
| NCT Number | NCT06973564 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 344 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Jacobio Pharmaceuticals Co., Ltd. |
| Last Updated on CT.gov | October 16, 2026 (17 hours ago) |
As of October 16, 2026: Clinical trial NCT06973564 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 4 locations across the United States. The study is sponsored by Jacobio Pharmaceuticals Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06973564 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06973564 was last updated 17 hours ago (October 16, 2026). HelloStudys verifies this status automatically.